Zhu, K., Nassar, M., Khosla, A. A., Singh, R. (2026). Real-world outcomes with atezolizumab versus durvalumab plus chemotherapy for extensive-stage small cell lung cancer: A TriNetX propensity-matched analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.11145